AstraZeneca PLC
Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All AZN news ›AstraZeneca (LSE:AZN) Puts AI Into Biologics Labs With New Discovery Tie Up
AstraZeneca (LSE:AZN) has launched a new AI-driven biologics discovery collaboration with Carterra, announced ahead of trading on 9 October 2026. The project focuses on large molecule biologics, aiming to shorten experimental decision…
Morning Movers: Summit Therapeutics jumps after AstraZeneca investment
Sstock futures have edged higher in early trading as technology stocks stabilize, but elevated oil prices and Treasury yields tied to ongoing Middle East tensions continue to temper risk appetite. In pre-market trading, S&P 500 futures…
In Brief Personalis, Tempus, AstraZeneca, Summit, ARUP, More
In Brief This Week: Personalis, Tempus, AstraZeneca, Summit, ARUP, FDA, Agilent, Abbvie, More Genome Web NEW YORK - Investment firm BTIG downgraded Personalis from Buy to Neutral this week based on the expectation that its acquisition by…
AstraZeneca CEO Highlights Summit Drug’s Potential in Cancer Treatment
IISc and IITs Lead Indian Representation in Global Top Two Percent Scientists List Indian Pharma Industry Looks Beyond the US to Expand Global Exports India’s Complex Molecules Opportunity: The Signal Beyond the GLP-1 Rush A New Awakening…
AstraZeneca (AZN) Seeks FDA Approval for New Lung Cancer Treatment. Can It Fuel Oncology Growth?
AZN shares lost about 14% year to date which is probably why it ranked 9th on our list of the 12 Best Beaten Down Growth Stocks To Buy Now. Developed in partnership with HUTCHMED, the combination is designed to treat patients with advanced…
Myriad, SOPHiA partner with AstraZeneca to use prostate cancer technology
Myriad and SOPHiA partner with AstraZeneca to apply PrGIS genomic instability scoring in prostate cancer trials, advancing HRD companion diagnostics. Read more here. - Myriad Genetics (MYGN) and SOPHiA Genetics (SOPH) will collaborate with…
‘Burn in hell’: Fired scientist’s death threats against AstraZeneca, Aetna officials land him in prison, but diatribes continue
Justin Dynlacht thought his employer and health insurer didn’t provide adequate coverage for Crohn’s disease, but took his complaints way too far. File - The Federal Detention Center in Philadelphia, where Justin Dynlacht is being held…
AstraZeneca PLC (AZN.L)
stock price, news, quote and history Yahoo Finance Singapore Singapore markets open in 1h 16m AstraZeneca PLC Overview Drug Manufacturers - General / Healthcare AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery,…
Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced ER-positive Breast Cancer
BioSpace Guardant Health Announces Approval in Europe of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced ER-positive Breast Cancer - Guardant360 CDx can now help identify cancer mutations…
AstraZeneca’s Trixeo approved in EU for asthma
pharmafile | October 8, 2026 | News story | | Asthma & COPD, AstraZeneca, EU The fixed-dose triple combination adds a long-acting muscarinic antagonist (LAMA) to ICS/LABA in a single inhaler. The European Commission approval follows a…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
tradingview.com326
-
marketscreener.com286
-
finance.yahoo.com202
-
seekingalpha.com92
-
themarketsdaily.com81
Measured across the 4Sciences news index. Headline tone is a simple word-based reading of the latest 120 headlines, not a forecast.